Global Bacteriophages (Phage) Products Market Growth 2026-2032
The global Bacteriophages (Phage) Products market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bacteriophages (Phage) Products Industry Forecast” looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2025, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2026 through 2032. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out by Type, by Application?
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection.
United States market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Bacteriophages (Phage) Products is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Bacteriophages (Phage) Products players cover Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Bacteriophages (Phage) Products Industry Forecast” looks at past sales and reviews total world Bacteriophages (Phage) Products sales in 2025, providing a comprehensive analysis by region and market sector of projected Bacteriophages (Phage) Products sales for 2026 through 2032. With Bacteriophages (Phage) Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophages (Phage) Products industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophages (Phage) Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophages (Phage) Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophages (Phage) Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophages (Phage) Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophages (Phage) Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophages (Phage) Products market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- DsDNA Type
- SsDNA Type
- SsRNA Type
- Others
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
What is the 10-year outlook for the global Bacteriophages (Phage) Products market?
What factors are driving Bacteriophages (Phage) Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacteriophages (Phage) Products market opportunities vary by end market size?
How does Bacteriophages (Phage) Products break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bacteriophages (Phage) Products Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bacteriophages (Phage) Products by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bacteriophages (Phage) Products by Country/Region, 2021, 2025 & 2032
2.2 Bacteriophages (Phage) Products Segment by Type
2.2.1 DsDNA Type
2.2.2 SsDNA Type
2.2.3 SsRNA Type
2.2.4 Others
2.2.5 Bacteriophages (Phage) Products Sales by Type
2.2.5.1 Global Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
2.2.5.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Bacteriophages (Phage) Products Sale Price by Type (2021-2026)
2.3 Bacteriophages (Phage) Products Segment by Application
2.3.1 Animal Health
2.3.2 Aquaculture
2.3.3 Agriculture
2.3.4 Food Industry
2.3.5 Others
2.3.6 Bacteriophages (Phage) Products Sales by Application
2.3.6.1 Global Bacteriophages (Phage) Products Sale Market Share by Application (2021-2026)
2.3.6.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Bacteriophages (Phage) Products Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bacteriophages (Phage) Products Breakdown Data by Company
3.1.1 Global Bacteriophages (Phage) Products Annual Sales by Company (2021-2026)
3.1.2 Global Bacteriophages (Phage) Products Sales Market Share by Company (2021-2026)
3.2 Global Bacteriophages (Phage) Products Annual Revenue by Company (2021-2026)
3.2.1 Global Bacteriophages (Phage) Products Revenue by Company (2021-2026)
3.2.2 Global Bacteriophages (Phage) Products Revenue Market Share by Company (2021-2026)
3.3 Global Bacteriophages (Phage) Products Sale Price by Company
3.4 Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacteriophages (Phage) Products Product Location Distribution
3.4.2 Players Bacteriophages (Phage) Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BACTERIOPHAGES (PHAGE) PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Bacteriophages (Phage) Products Market Size by Geographic Region (2021-2026)
4.1.1 Global Bacteriophages (Phage) Products Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bacteriophages (Phage) Products Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bacteriophages (Phage) Products Market Size by Country/Region (2021-2026)
4.2.1 Global Bacteriophages (Phage) Products Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bacteriophages (Phage) Products Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bacteriophages (Phage) Products Sales Growth
4.4 APAC Bacteriophages (Phage) Products Sales Growth
4.5 Europe Bacteriophages (Phage) Products Sales Growth
4.6 Middle East & Africa Bacteriophages (Phage) Products Sales Growth
5 AMERICAS
5.1 Americas Bacteriophages (Phage) Products Sales by Country
5.1.1 Americas Bacteriophages (Phage) Products Sales by Country (2021-2026)
5.1.2 Americas Bacteriophages (Phage) Products Revenue by Country (2021-2026)
5.2 Americas Bacteriophages (Phage) Products Sales by Type (2021-2026)
5.3 Americas Bacteriophages (Phage) Products Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophages (Phage) Products Sales by Region
6.1.1 APAC Bacteriophages (Phage) Products Sales by Region (2021-2026)
6.1.2 APAC Bacteriophages (Phage) Products Revenue by Region (2021-2026)
6.2 APAC Bacteriophages (Phage) Products Sales by Type (2021-2026)
6.3 APAC Bacteriophages (Phage) Products Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bacteriophages (Phage) Products by Country
7.1.1 Europe Bacteriophages (Phage) Products Sales by Country (2021-2026)
7.1.2 Europe Bacteriophages (Phage) Products Revenue by Country (2021-2026)
7.2 Europe Bacteriophages (Phage) Products Sales by Type (2021-2026)
7.3 Europe Bacteriophages (Phage) Products Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bacteriophages (Phage) Products by Country
8.1.1 Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bacteriophages (Phage) Products Revenue by Country (2021-2026)
8.2 Middle East & Africa Bacteriophages (Phage) Products Sales by Type (2021-2026)
8.3 Middle East & Africa Bacteriophages (Phage) Products Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products
10.3 Manufacturing Process Analysis of Bacteriophages (Phage) Products
10.4 Industry Chain Structure of Bacteriophages (Phage) Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacteriophages (Phage) Products Distributors
11.3 Bacteriophages (Phage) Products Customer
12 WORLD FORECAST REVIEW FOR BACTERIOPHAGES (PHAGE) PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Bacteriophages (Phage) Products Market Size Forecast by Region
12.1.1 Global Bacteriophages (Phage) Products Forecast by Region (2027-2032)
12.1.2 Global Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bacteriophages (Phage) Products Forecast by Type (2027-2032)
12.7 Global Bacteriophages (Phage) Products Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Proteon Pharmaceuticals
13.1.1 Proteon Pharmaceuticals Company Information
13.1.2 Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications
13.1.3 Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Proteon Pharmaceuticals Main Business Overview
13.1.5 Proteon Pharmaceuticals Latest Developments
13.2 Phagelux
13.2.1 Phagelux Company Information
13.2.2 Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications
13.2.3 Phagelux Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Phagelux Main Business Overview
13.2.5 Phagelux Latest Developments
13.3 Intralytix
13.3.1 Intralytix Company Information
13.3.2 Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.3.3 Intralytix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intralytix Main Business Overview
13.3.5 Intralytix Latest Developments
13.4 Micreos
13.4.1 Micreos Company Information
13.4.2 Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications
13.4.3 Micreos Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Micreos Main Business Overview
13.4.5 Micreos Latest Developments
13.5 Eliava BioPreparations
13.5.1 Eliava BioPreparations Company Information
13.5.2 Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications
13.5.3 Eliava BioPreparations Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eliava BioPreparations Main Business Overview
13.5.5 Eliava BioPreparations Latest Developments
13.6 Locus Biosciences,Inc
13.6.1 Locus Biosciences,Inc Company Information
13.6.2 Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications
13.6.3 Locus Biosciences,Inc Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Locus Biosciences,Inc Main Business Overview
13.6.5 Locus Biosciences,Inc Latest Developments
13.7 Pharmex Group,LLC
13.7.1 Pharmex Group,LLC Company Information
13.7.2 Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications
13.7.3 Pharmex Group,LLC Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pharmex Group,LLC Main Business Overview
13.7.5 Pharmex Group,LLC Latest Developments
13.8 Pherecydes Pharma
13.8.1 Pherecydes Pharma Company Information
13.8.2 Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications
13.8.3 Pherecydes Pharma Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pherecydes Pharma Main Business Overview
13.8.5 Pherecydes Pharma Latest Developments
13.9 APS Biocontrol Ltd. (APS)
13.9.1 APS Biocontrol Ltd. (APS) Company Information
13.9.2 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications
13.9.3 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 APS Biocontrol Ltd. (APS) Main Business Overview
13.9.5 APS Biocontrol Ltd. (APS) Latest Developments
13.10 Qingdao Phagepharm Bio-tech
13.10.1 Qingdao Phagepharm Bio-tech Company Information
13.10.2 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications
13.10.3 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Qingdao Phagepharm Bio-tech Main Business Overview
13.10.5 Qingdao Phagepharm Bio-tech Latest Developments
13.11 Fixed-Phage Limited
13.11.1 Fixed-Phage Limited Company Information
13.11.2 Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications
13.11.3 Fixed-Phage Limited Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Fixed-Phage Limited Main Business Overview
13.11.5 Fixed-Phage Limited Latest Developments
13.12 Zeptometrix
13.12.1 Zeptometrix Company Information
13.12.2 Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.12.3 Zeptometrix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zeptometrix Main Business Overview
13.12.5 Zeptometrix Latest Developments
13.13 Phage International, Inc.
13.13.1 Phage International, Inc. Company Information
13.13.2 Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.13.3 Phage International, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Phage International, Inc. Main Business Overview
13.13.5 Phage International, Inc. Latest Developments
13.14 MicroMir
13.14.1 MicroMir Company Information
13.14.2 MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications
13.14.3 MicroMir Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 MicroMir Main Business Overview
13.14.5 MicroMir Latest Developments
13.15 iNtODEWORLD, Inc.
13.15.1 iNtODEWORLD, Inc. Company Information
13.15.2 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.15.3 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 iNtODEWORLD, Inc. Main Business Overview
13.15.5 iNtODEWORLD, Inc. Latest Developments
13.16 NEXTBIOTICS
13.16.1 NEXTBIOTICS Company Information
13.16.2 NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications
13.16.3 NEXTBIOTICS Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 NEXTBIOTICS Main Business Overview
13.16.5 NEXTBIOTICS Latest Developments
13.17 Armata Pharmaceuticals, Inc.
13.17.1 Armata Pharmaceuticals, Inc. Company Information
13.17.2 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.17.3 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Armata Pharmaceuticals, Inc. Main Business Overview
13.17.5 Armata Pharmaceuticals, Inc. Latest Developments
13.18 Innophage
13.18.1 Innophage Company Information
13.18.2 Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.18.3 Innophage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Innophage Main Business Overview
13.18.5 Innophage Latest Developments
13.19 Adaptive Phage Therapeutics
13.19.1 Adaptive Phage Therapeutics Company Information
13.19.2 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications
13.19.3 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Adaptive Phage Therapeutics Main Business Overview
13.19.5 Adaptive Phage Therapeutics Latest Developments
13.20 TechnoPhage
13.20.1 TechnoPhage Company Information
13.20.2 TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.20.3 TechnoPhage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 TechnoPhage Main Business Overview
13.20.5 TechnoPhage Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bacteriophages (Phage) Products Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Bacteriophages (Phage) Products by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Bacteriophages (Phage) Products by Country/Region, 2021, 2025 & 2032
2.2 Bacteriophages (Phage) Products Segment by Type
2.2.1 DsDNA Type
2.2.2 SsDNA Type
2.2.3 SsRNA Type
2.2.4 Others
2.2.5 Bacteriophages (Phage) Products Sales by Type
2.2.5.1 Global Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
2.2.5.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Bacteriophages (Phage) Products Sale Price by Type (2021-2026)
2.3 Bacteriophages (Phage) Products Segment by Application
2.3.1 Animal Health
2.3.2 Aquaculture
2.3.3 Agriculture
2.3.4 Food Industry
2.3.5 Others
2.3.6 Bacteriophages (Phage) Products Sales by Application
2.3.6.1 Global Bacteriophages (Phage) Products Sale Market Share by Application (2021-2026)
2.3.6.2 Global Bacteriophages (Phage) Products Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Bacteriophages (Phage) Products Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Bacteriophages (Phage) Products Breakdown Data by Company
3.1.1 Global Bacteriophages (Phage) Products Annual Sales by Company (2021-2026)
3.1.2 Global Bacteriophages (Phage) Products Sales Market Share by Company (2021-2026)
3.2 Global Bacteriophages (Phage) Products Annual Revenue by Company (2021-2026)
3.2.1 Global Bacteriophages (Phage) Products Revenue by Company (2021-2026)
3.2.2 Global Bacteriophages (Phage) Products Revenue Market Share by Company (2021-2026)
3.3 Global Bacteriophages (Phage) Products Sale Price by Company
3.4 Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacteriophages (Phage) Products Product Location Distribution
3.4.2 Players Bacteriophages (Phage) Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BACTERIOPHAGES (PHAGE) PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Bacteriophages (Phage) Products Market Size by Geographic Region (2021-2026)
4.1.1 Global Bacteriophages (Phage) Products Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Bacteriophages (Phage) Products Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Bacteriophages (Phage) Products Market Size by Country/Region (2021-2026)
4.2.1 Global Bacteriophages (Phage) Products Annual Sales by Country/Region (2021-2026)
4.2.2 Global Bacteriophages (Phage) Products Annual Revenue by Country/Region (2021-2026)
4.3 Americas Bacteriophages (Phage) Products Sales Growth
4.4 APAC Bacteriophages (Phage) Products Sales Growth
4.5 Europe Bacteriophages (Phage) Products Sales Growth
4.6 Middle East & Africa Bacteriophages (Phage) Products Sales Growth
5 AMERICAS
5.1 Americas Bacteriophages (Phage) Products Sales by Country
5.1.1 Americas Bacteriophages (Phage) Products Sales by Country (2021-2026)
5.1.2 Americas Bacteriophages (Phage) Products Revenue by Country (2021-2026)
5.2 Americas Bacteriophages (Phage) Products Sales by Type (2021-2026)
5.3 Americas Bacteriophages (Phage) Products Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophages (Phage) Products Sales by Region
6.1.1 APAC Bacteriophages (Phage) Products Sales by Region (2021-2026)
6.1.2 APAC Bacteriophages (Phage) Products Revenue by Region (2021-2026)
6.2 APAC Bacteriophages (Phage) Products Sales by Type (2021-2026)
6.3 APAC Bacteriophages (Phage) Products Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bacteriophages (Phage) Products by Country
7.1.1 Europe Bacteriophages (Phage) Products Sales by Country (2021-2026)
7.1.2 Europe Bacteriophages (Phage) Products Revenue by Country (2021-2026)
7.2 Europe Bacteriophages (Phage) Products Sales by Type (2021-2026)
7.3 Europe Bacteriophages (Phage) Products Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bacteriophages (Phage) Products by Country
8.1.1 Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2021-2026)
8.1.2 Middle East & Africa Bacteriophages (Phage) Products Revenue by Country (2021-2026)
8.2 Middle East & Africa Bacteriophages (Phage) Products Sales by Type (2021-2026)
8.3 Middle East & Africa Bacteriophages (Phage) Products Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products
10.3 Manufacturing Process Analysis of Bacteriophages (Phage) Products
10.4 Industry Chain Structure of Bacteriophages (Phage) Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacteriophages (Phage) Products Distributors
11.3 Bacteriophages (Phage) Products Customer
12 WORLD FORECAST REVIEW FOR BACTERIOPHAGES (PHAGE) PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Bacteriophages (Phage) Products Market Size Forecast by Region
12.1.1 Global Bacteriophages (Phage) Products Forecast by Region (2027-2032)
12.1.2 Global Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Bacteriophages (Phage) Products Forecast by Type (2027-2032)
12.7 Global Bacteriophages (Phage) Products Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Proteon Pharmaceuticals
13.1.1 Proteon Pharmaceuticals Company Information
13.1.2 Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications
13.1.3 Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Proteon Pharmaceuticals Main Business Overview
13.1.5 Proteon Pharmaceuticals Latest Developments
13.2 Phagelux
13.2.1 Phagelux Company Information
13.2.2 Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications
13.2.3 Phagelux Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Phagelux Main Business Overview
13.2.5 Phagelux Latest Developments
13.3 Intralytix
13.3.1 Intralytix Company Information
13.3.2 Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.3.3 Intralytix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Intralytix Main Business Overview
13.3.5 Intralytix Latest Developments
13.4 Micreos
13.4.1 Micreos Company Information
13.4.2 Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications
13.4.3 Micreos Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Micreos Main Business Overview
13.4.5 Micreos Latest Developments
13.5 Eliava BioPreparations
13.5.1 Eliava BioPreparations Company Information
13.5.2 Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications
13.5.3 Eliava BioPreparations Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eliava BioPreparations Main Business Overview
13.5.5 Eliava BioPreparations Latest Developments
13.6 Locus Biosciences,Inc
13.6.1 Locus Biosciences,Inc Company Information
13.6.2 Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications
13.6.3 Locus Biosciences,Inc Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Locus Biosciences,Inc Main Business Overview
13.6.5 Locus Biosciences,Inc Latest Developments
13.7 Pharmex Group,LLC
13.7.1 Pharmex Group,LLC Company Information
13.7.2 Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications
13.7.3 Pharmex Group,LLC Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Pharmex Group,LLC Main Business Overview
13.7.5 Pharmex Group,LLC Latest Developments
13.8 Pherecydes Pharma
13.8.1 Pherecydes Pharma Company Information
13.8.2 Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications
13.8.3 Pherecydes Pharma Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pherecydes Pharma Main Business Overview
13.8.5 Pherecydes Pharma Latest Developments
13.9 APS Biocontrol Ltd. (APS)
13.9.1 APS Biocontrol Ltd. (APS) Company Information
13.9.2 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications
13.9.3 APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 APS Biocontrol Ltd. (APS) Main Business Overview
13.9.5 APS Biocontrol Ltd. (APS) Latest Developments
13.10 Qingdao Phagepharm Bio-tech
13.10.1 Qingdao Phagepharm Bio-tech Company Information
13.10.2 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications
13.10.3 Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Qingdao Phagepharm Bio-tech Main Business Overview
13.10.5 Qingdao Phagepharm Bio-tech Latest Developments
13.11 Fixed-Phage Limited
13.11.1 Fixed-Phage Limited Company Information
13.11.2 Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications
13.11.3 Fixed-Phage Limited Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Fixed-Phage Limited Main Business Overview
13.11.5 Fixed-Phage Limited Latest Developments
13.12 Zeptometrix
13.12.1 Zeptometrix Company Information
13.12.2 Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications
13.12.3 Zeptometrix Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zeptometrix Main Business Overview
13.12.5 Zeptometrix Latest Developments
13.13 Phage International, Inc.
13.13.1 Phage International, Inc. Company Information
13.13.2 Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.13.3 Phage International, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Phage International, Inc. Main Business Overview
13.13.5 Phage International, Inc. Latest Developments
13.14 MicroMir
13.14.1 MicroMir Company Information
13.14.2 MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications
13.14.3 MicroMir Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 MicroMir Main Business Overview
13.14.5 MicroMir Latest Developments
13.15 iNtODEWORLD, Inc.
13.15.1 iNtODEWORLD, Inc. Company Information
13.15.2 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.15.3 iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 iNtODEWORLD, Inc. Main Business Overview
13.15.5 iNtODEWORLD, Inc. Latest Developments
13.16 NEXTBIOTICS
13.16.1 NEXTBIOTICS Company Information
13.16.2 NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications
13.16.3 NEXTBIOTICS Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 NEXTBIOTICS Main Business Overview
13.16.5 NEXTBIOTICS Latest Developments
13.17 Armata Pharmaceuticals, Inc.
13.17.1 Armata Pharmaceuticals, Inc. Company Information
13.17.2 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
13.17.3 Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Armata Pharmaceuticals, Inc. Main Business Overview
13.17.5 Armata Pharmaceuticals, Inc. Latest Developments
13.18 Innophage
13.18.1 Innophage Company Information
13.18.2 Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.18.3 Innophage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Innophage Main Business Overview
13.18.5 Innophage Latest Developments
13.19 Adaptive Phage Therapeutics
13.19.1 Adaptive Phage Therapeutics Company Information
13.19.2 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications
13.19.3 Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Adaptive Phage Therapeutics Main Business Overview
13.19.5 Adaptive Phage Therapeutics Latest Developments
13.20 TechnoPhage
13.20.1 TechnoPhage Company Information
13.20.2 TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications
13.20.3 TechnoPhage Bacteriophages (Phage) Products Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 TechnoPhage Main Business Overview
13.20.5 TechnoPhage Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bacteriophages (Phage) Products Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bacteriophages (Phage) Products Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DsDNA Type
Table 4. Major Players of SsDNA Type
Table 5. Major Players of SsRNA Type
Table 6. Major Players of Others
Table 7. Global Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 8. Global Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Table 9. Global Bacteriophages (Phage) Products Revenue by Type (2021-2026) & ($ million)
Table 10. Global Bacteriophages (Phage) Products Revenue Market Share by Type (2021-2026)
Table 11. Global Bacteriophages (Phage) Products Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Bacteriophages (Phage) Products Sale by Application (2021-2026) & (K Units)
Table 13. Global Bacteriophages (Phage) Products Sale Market Share by Application (2021-2026)
Table 14. Global Bacteriophages (Phage) Products Revenue by Application (2021-2026) & ($ million)
Table 15. Global Bacteriophages (Phage) Products Revenue Market Share by Application (2021-2026)
Table 16. Global Bacteriophages (Phage) Products Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Bacteriophages (Phage) Products Sales by Company (2021-2026) & (K Units)
Table 18. Global Bacteriophages (Phage) Products Sales Market Share by Company (2021-2026)
Table 19. Global Bacteriophages (Phage) Products Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Bacteriophages (Phage) Products Revenue Market Share by Company (2021-2026)
Table 21. Global Bacteriophages (Phage) Products Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution and Sales Area
Table 23. Players Bacteriophages (Phage) Products Products Offered
Table 24. Bacteriophages (Phage) Products Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Bacteriophages (Phage) Products Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Bacteriophages (Phage) Products Sales Market Share Geographic Region (2021-2026)
Table 29. Global Bacteriophages (Phage) Products Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Bacteriophages (Phage) Products Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Bacteriophages (Phage) Products Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Bacteriophages (Phage) Products Sales Market Share by Country/Region (2021-2026)
Table 33. Global Bacteriophages (Phage) Products Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Bacteriophages (Phage) Products Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 36. Americas Bacteriophages (Phage) Products Sales Market Share by Country (2021-2026)
Table 37. Americas Bacteriophages (Phage) Products Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 39. Americas Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 40. APAC Bacteriophages (Phage) Products Sales by Region (2021-2026) & (K Units)
Table 41. APAC Bacteriophages (Phage) Products Sales Market Share by Region (2021-2026)
Table 42. APAC Bacteriophages (Phage) Products Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 44. APAC Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 45. Europe Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 46. Europe Bacteriophages (Phage) Products Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 48. Europe Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Bacteriophages (Phage) Products
Table 54. Key Market Challenges & Risks of Bacteriophages (Phage) Products
Table 55. Key Industry Trends of Bacteriophages (Phage) Products
Table 56. Bacteriophages (Phage) Products Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Bacteriophages (Phage) Products Distributors List
Table 59. Bacteriophages (Phage) Products Customer List
Table 60. Global Bacteriophages (Phage) Products Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Bacteriophages (Phage) Products Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Bacteriophages (Phage) Products Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Bacteriophages (Phage) Products Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Bacteriophages (Phage) Products Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Bacteriophages (Phage) Products Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Bacteriophages (Phage) Products Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Bacteriophages (Phage) Products Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Bacteriophages (Phage) Products Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Bacteriophages (Phage) Products Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Proteon Pharmaceuticals Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 75. Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 76. Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Proteon Pharmaceuticals Main Business
Table 78. Proteon Pharmaceuticals Latest Developments
Table 79. Phagelux Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 81. Phagelux Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Phagelux Main Business
Table 83. Phagelux Latest Developments
Table 84. Intralytix Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 86. Intralytix Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Intralytix Main Business
Table 88. Intralytix Latest Developments
Table 89. Micreos Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 91. Micreos Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Micreos Main Business
Table 93. Micreos Latest Developments
Table 94. Eliava BioPreparations Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 96. Eliava BioPreparations Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Eliava BioPreparations Main Business
Table 98. Eliava BioPreparations Latest Developments
Table 99. Locus Biosciences,Inc Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 101. Locus Biosciences,Inc Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Locus Biosciences,Inc Main Business
Table 103. Locus Biosciences,Inc Latest Developments
Table 104. Pharmex Group,LLC Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 106. Pharmex Group,LLC Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Pharmex Group,LLC Main Business
Table 108. Pharmex Group,LLC Latest Developments
Table 109. Pherecydes Pharma Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 111. Pherecydes Pharma Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pherecydes Pharma Main Business
Table 113. Pherecydes Pharma Latest Developments
Table 114. APS Biocontrol Ltd. (APS) Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 115. APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 116. APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. APS Biocontrol Ltd. (APS) Main Business
Table 118. APS Biocontrol Ltd. (APS) Latest Developments
Table 119. Qingdao Phagepharm Bio-tech Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 120. Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 121. Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Qingdao Phagepharm Bio-tech Main Business
Table 123. Qingdao Phagepharm Bio-tech Latest Developments
Table 124. Fixed-Phage Limited Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 125. Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 126. Fixed-Phage Limited Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Fixed-Phage Limited Main Business
Table 128. Fixed-Phage Limited Latest Developments
Table 129. Zeptometrix Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 130. Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 131. Zeptometrix Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Zeptometrix Main Business
Table 133. Zeptometrix Latest Developments
Table 134. Phage International, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 135. Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 136. Phage International, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Phage International, Inc. Main Business
Table 138. Phage International, Inc. Latest Developments
Table 139. MicroMir Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 140. MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 141. MicroMir Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. MicroMir Main Business
Table 143. MicroMir Latest Developments
Table 144. iNtODEWORLD, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 145. iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 146. iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. iNtODEWORLD, Inc. Main Business
Table 148. iNtODEWORLD, Inc. Latest Developments
Table 149. NEXTBIOTICS Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 150. NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 151. NEXTBIOTICS Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. NEXTBIOTICS Main Business
Table 153. NEXTBIOTICS Latest Developments
Table 154. Armata Pharmaceuticals, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 155. Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 156. Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Armata Pharmaceuticals, Inc. Main Business
Table 158. Armata Pharmaceuticals, Inc. Latest Developments
Table 159. Innophage Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 160. Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 161. Innophage Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Innophage Main Business
Table 163. Innophage Latest Developments
Table 164. Adaptive Phage Therapeutics Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 165. Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 166. Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Adaptive Phage Therapeutics Main Business
Table 168. Adaptive Phage Therapeutics Latest Developments
Table 169. TechnoPhage Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 170. TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 171. TechnoPhage Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. TechnoPhage Main Business
Table 173. TechnoPhage Latest Developments
Table 1. Bacteriophages (Phage) Products Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Bacteriophages (Phage) Products Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DsDNA Type
Table 4. Major Players of SsDNA Type
Table 5. Major Players of SsRNA Type
Table 6. Major Players of Others
Table 7. Global Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 8. Global Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Table 9. Global Bacteriophages (Phage) Products Revenue by Type (2021-2026) & ($ million)
Table 10. Global Bacteriophages (Phage) Products Revenue Market Share by Type (2021-2026)
Table 11. Global Bacteriophages (Phage) Products Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Bacteriophages (Phage) Products Sale by Application (2021-2026) & (K Units)
Table 13. Global Bacteriophages (Phage) Products Sale Market Share by Application (2021-2026)
Table 14. Global Bacteriophages (Phage) Products Revenue by Application (2021-2026) & ($ million)
Table 15. Global Bacteriophages (Phage) Products Revenue Market Share by Application (2021-2026)
Table 16. Global Bacteriophages (Phage) Products Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Bacteriophages (Phage) Products Sales by Company (2021-2026) & (K Units)
Table 18. Global Bacteriophages (Phage) Products Sales Market Share by Company (2021-2026)
Table 19. Global Bacteriophages (Phage) Products Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Bacteriophages (Phage) Products Revenue Market Share by Company (2021-2026)
Table 21. Global Bacteriophages (Phage) Products Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Bacteriophages (Phage) Products Producing Area Distribution and Sales Area
Table 23. Players Bacteriophages (Phage) Products Products Offered
Table 24. Bacteriophages (Phage) Products Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Bacteriophages (Phage) Products Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Bacteriophages (Phage) Products Sales Market Share Geographic Region (2021-2026)
Table 29. Global Bacteriophages (Phage) Products Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Bacteriophages (Phage) Products Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Bacteriophages (Phage) Products Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Bacteriophages (Phage) Products Sales Market Share by Country/Region (2021-2026)
Table 33. Global Bacteriophages (Phage) Products Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Bacteriophages (Phage) Products Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 36. Americas Bacteriophages (Phage) Products Sales Market Share by Country (2021-2026)
Table 37. Americas Bacteriophages (Phage) Products Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 39. Americas Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 40. APAC Bacteriophages (Phage) Products Sales by Region (2021-2026) & (K Units)
Table 41. APAC Bacteriophages (Phage) Products Sales Market Share by Region (2021-2026)
Table 42. APAC Bacteriophages (Phage) Products Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 44. APAC Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 45. Europe Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 46. Europe Bacteriophages (Phage) Products Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 48. Europe Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Bacteriophages (Phage) Products Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Bacteriophages (Phage) Products Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Bacteriophages (Phage) Products Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Bacteriophages (Phage) Products
Table 54. Key Market Challenges & Risks of Bacteriophages (Phage) Products
Table 55. Key Industry Trends of Bacteriophages (Phage) Products
Table 56. Bacteriophages (Phage) Products Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Bacteriophages (Phage) Products Distributors List
Table 59. Bacteriophages (Phage) Products Customer List
Table 60. Global Bacteriophages (Phage) Products Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Bacteriophages (Phage) Products Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Bacteriophages (Phage) Products Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Bacteriophages (Phage) Products Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Bacteriophages (Phage) Products Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Bacteriophages (Phage) Products Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Bacteriophages (Phage) Products Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Bacteriophages (Phage) Products Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Bacteriophages (Phage) Products Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Bacteriophages (Phage) Products Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Bacteriophages (Phage) Products Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Bacteriophages (Phage) Products Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Proteon Pharmaceuticals Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 75. Proteon Pharmaceuticals Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 76. Proteon Pharmaceuticals Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Proteon Pharmaceuticals Main Business
Table 78. Proteon Pharmaceuticals Latest Developments
Table 79. Phagelux Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Phagelux Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 81. Phagelux Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Phagelux Main Business
Table 83. Phagelux Latest Developments
Table 84. Intralytix Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Intralytix Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 86. Intralytix Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Intralytix Main Business
Table 88. Intralytix Latest Developments
Table 89. Micreos Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Micreos Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 91. Micreos Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Micreos Main Business
Table 93. Micreos Latest Developments
Table 94. Eliava BioPreparations Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Eliava BioPreparations Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 96. Eliava BioPreparations Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Eliava BioPreparations Main Business
Table 98. Eliava BioPreparations Latest Developments
Table 99. Locus Biosciences,Inc Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Locus Biosciences,Inc Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 101. Locus Biosciences,Inc Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Locus Biosciences,Inc Main Business
Table 103. Locus Biosciences,Inc Latest Developments
Table 104. Pharmex Group,LLC Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Pharmex Group,LLC Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 106. Pharmex Group,LLC Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Pharmex Group,LLC Main Business
Table 108. Pharmex Group,LLC Latest Developments
Table 109. Pherecydes Pharma Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Pherecydes Pharma Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 111. Pherecydes Pharma Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Pherecydes Pharma Main Business
Table 113. Pherecydes Pharma Latest Developments
Table 114. APS Biocontrol Ltd. (APS) Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 115. APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 116. APS Biocontrol Ltd. (APS) Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. APS Biocontrol Ltd. (APS) Main Business
Table 118. APS Biocontrol Ltd. (APS) Latest Developments
Table 119. Qingdao Phagepharm Bio-tech Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 120. Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 121. Qingdao Phagepharm Bio-tech Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Qingdao Phagepharm Bio-tech Main Business
Table 123. Qingdao Phagepharm Bio-tech Latest Developments
Table 124. Fixed-Phage Limited Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 125. Fixed-Phage Limited Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 126. Fixed-Phage Limited Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Fixed-Phage Limited Main Business
Table 128. Fixed-Phage Limited Latest Developments
Table 129. Zeptometrix Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 130. Zeptometrix Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 131. Zeptometrix Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Zeptometrix Main Business
Table 133. Zeptometrix Latest Developments
Table 134. Phage International, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 135. Phage International, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 136. Phage International, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Phage International, Inc. Main Business
Table 138. Phage International, Inc. Latest Developments
Table 139. MicroMir Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 140. MicroMir Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 141. MicroMir Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. MicroMir Main Business
Table 143. MicroMir Latest Developments
Table 144. iNtODEWORLD, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 145. iNtODEWORLD, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 146. iNtODEWORLD, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. iNtODEWORLD, Inc. Main Business
Table 148. iNtODEWORLD, Inc. Latest Developments
Table 149. NEXTBIOTICS Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 150. NEXTBIOTICS Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 151. NEXTBIOTICS Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. NEXTBIOTICS Main Business
Table 153. NEXTBIOTICS Latest Developments
Table 154. Armata Pharmaceuticals, Inc. Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 155. Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 156. Armata Pharmaceuticals, Inc. Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Armata Pharmaceuticals, Inc. Main Business
Table 158. Armata Pharmaceuticals, Inc. Latest Developments
Table 159. Innophage Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 160. Innophage Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 161. Innophage Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Innophage Main Business
Table 163. Innophage Latest Developments
Table 164. Adaptive Phage Therapeutics Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 165. Adaptive Phage Therapeutics Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 166. Adaptive Phage Therapeutics Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Adaptive Phage Therapeutics Main Business
Table 168. Adaptive Phage Therapeutics Latest Developments
Table 169. TechnoPhage Basic Information, Bacteriophages (Phage) Products Manufacturing Base, Sales Area and Its Competitors
Table 170. TechnoPhage Bacteriophages (Phage) Products Product Portfolios and Specifications
Table 171. TechnoPhage Bacteriophages (Phage) Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. TechnoPhage Main Business
Table 173. TechnoPhage Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bacteriophages (Phage) Products
Figure 2. Bacteriophages (Phage) Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bacteriophages (Phage) Products Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Bacteriophages (Phage) Products Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bacteriophages (Phage) Products Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bacteriophages (Phage) Products Sales Market Share by Country/Region (2025)
Figure 10. Bacteriophages (Phage) Products Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DsDNA Type
Figure 12. Product Picture of SsDNA Type
Figure 13. Product Picture of SsRNA Type
Figure 14. Product Picture of Others
Figure 15. Global Bacteriophages (Phage) Products Sales Market Share by Type in 2026
Figure 16. Global Bacteriophages (Phage) Products Revenue Market Share by Type (2021-2026)
Figure 17. Bacteriophages (Phage) Products Consumed in Animal Health
Figure 18. Global Bacteriophages (Phage) Products Market: Animal Health (2021-2026) & (K Units)
Figure 19. Bacteriophages (Phage) Products Consumed in Aquaculture
Figure 20. Global Bacteriophages (Phage) Products Market: Aquaculture (2021-2026) & (K Units)
Figure 21. Bacteriophages (Phage) Products Consumed in Agriculture
Figure 22. Global Bacteriophages (Phage) Products Market: Agriculture (2021-2026) & (K Units)
Figure 23. Bacteriophages (Phage) Products Consumed in Food Industry
Figure 24. Global Bacteriophages (Phage) Products Market: Food Industry (2021-2026) & (K Units)
Figure 25. Bacteriophages (Phage) Products Consumed in Others
Figure 26. Global Bacteriophages (Phage) Products Market: Others (2021-2026) & (K Units)
Figure 27. Global Bacteriophages (Phage) Products Sale Market Share by Application (2025)
Figure 28. Global Bacteriophages (Phage) Products Revenue Market Share by Application in 2026
Figure 29. Bacteriophages (Phage) Products Sales by Company in 2026 (K Units)
Figure 30. Global Bacteriophages (Phage) Products Sales Market Share by Company in 2026
Figure 31. Bacteriophages (Phage) Products Revenue by Company in 2026 ($ millions)
Figure 32. Global Bacteriophages (Phage) Products Revenue Market Share by Company in 2026
Figure 33. Global Bacteriophages (Phage) Products Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Bacteriophages (Phage) Products Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 36. Americas Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 37. APAC Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 38. APAC Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 39. Europe Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 40. Europe Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 43. Americas Bacteriophages (Phage) Products Sales Market Share by Country in 2026
Figure 44. Americas Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Figure 45. Americas Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 46. Americas Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 47. United States Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Bacteriophages (Phage) Products Sales Market Share by Region in 2026
Figure 52. APAC Bacteriophages (Phage) Products Revenue Market Share by Region (2021-2026)
Figure 53. APAC Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 54. APAC Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 55. China Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 59. India Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Bacteriophages (Phage) Products Sales Market Share by Country in 2026
Figure 63. Europe Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Figure 64. Europe Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 65. Europe Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 66. Germany Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 67. France Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 74. Egypt Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products in 2026
Figure 80. Manufacturing Process Analysis of Bacteriophages (Phage) Products
Figure 81. Industry Chain Structure of Bacteriophages (Phage) Products
Figure 82. Channels of Distribution
Figure 83. Global Bacteriophages (Phage) Products Sales Market Forecast by Region (2027-2032)
Figure 84. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Bacteriophages (Phage) Products Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Bacteriophages (Phage) Products Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Bacteriophages (Phage) Products
Figure 2. Bacteriophages (Phage) Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bacteriophages (Phage) Products Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Bacteriophages (Phage) Products Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Bacteriophages (Phage) Products Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Bacteriophages (Phage) Products Sales Market Share by Country/Region (2025)
Figure 10. Bacteriophages (Phage) Products Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of DsDNA Type
Figure 12. Product Picture of SsDNA Type
Figure 13. Product Picture of SsRNA Type
Figure 14. Product Picture of Others
Figure 15. Global Bacteriophages (Phage) Products Sales Market Share by Type in 2026
Figure 16. Global Bacteriophages (Phage) Products Revenue Market Share by Type (2021-2026)
Figure 17. Bacteriophages (Phage) Products Consumed in Animal Health
Figure 18. Global Bacteriophages (Phage) Products Market: Animal Health (2021-2026) & (K Units)
Figure 19. Bacteriophages (Phage) Products Consumed in Aquaculture
Figure 20. Global Bacteriophages (Phage) Products Market: Aquaculture (2021-2026) & (K Units)
Figure 21. Bacteriophages (Phage) Products Consumed in Agriculture
Figure 22. Global Bacteriophages (Phage) Products Market: Agriculture (2021-2026) & (K Units)
Figure 23. Bacteriophages (Phage) Products Consumed in Food Industry
Figure 24. Global Bacteriophages (Phage) Products Market: Food Industry (2021-2026) & (K Units)
Figure 25. Bacteriophages (Phage) Products Consumed in Others
Figure 26. Global Bacteriophages (Phage) Products Market: Others (2021-2026) & (K Units)
Figure 27. Global Bacteriophages (Phage) Products Sale Market Share by Application (2025)
Figure 28. Global Bacteriophages (Phage) Products Revenue Market Share by Application in 2026
Figure 29. Bacteriophages (Phage) Products Sales by Company in 2026 (K Units)
Figure 30. Global Bacteriophages (Phage) Products Sales Market Share by Company in 2026
Figure 31. Bacteriophages (Phage) Products Revenue by Company in 2026 ($ millions)
Figure 32. Global Bacteriophages (Phage) Products Revenue Market Share by Company in 2026
Figure 33. Global Bacteriophages (Phage) Products Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Bacteriophages (Phage) Products Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 36. Americas Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 37. APAC Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 38. APAC Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 39. Europe Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 40. Europe Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Bacteriophages (Phage) Products Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Bacteriophages (Phage) Products Revenue 2021-2026 ($ millions)
Figure 43. Americas Bacteriophages (Phage) Products Sales Market Share by Country in 2026
Figure 44. Americas Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Figure 45. Americas Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 46. Americas Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 47. United States Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Bacteriophages (Phage) Products Sales Market Share by Region in 2026
Figure 52. APAC Bacteriophages (Phage) Products Revenue Market Share by Region (2021-2026)
Figure 53. APAC Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 54. APAC Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 55. China Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 59. India Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Bacteriophages (Phage) Products Sales Market Share by Country in 2026
Figure 63. Europe Bacteriophages (Phage) Products Revenue Market Share by Country (2021-2026)
Figure 64. Europe Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 65. Europe Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 66. Germany Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 67. France Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Bacteriophages (Phage) Products Sales Market Share by Application (2021-2026)
Figure 74. Egypt Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Bacteriophages (Phage) Products Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Bacteriophages (Phage) Products in 2026
Figure 80. Manufacturing Process Analysis of Bacteriophages (Phage) Products
Figure 81. Industry Chain Structure of Bacteriophages (Phage) Products
Figure 82. Channels of Distribution
Figure 83. Global Bacteriophages (Phage) Products Sales Market Forecast by Region (2027-2032)
Figure 84. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Bacteriophages (Phage) Products Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Bacteriophages (Phage) Products Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Bacteriophages (Phage) Products Revenue Market Share Forecast by Application (2027-2032)
